Pharmaron Beijing Co Ltd
SZSE:300759

Watchlist Manager
Pharmaron Beijing Co Ltd Logo
Pharmaron Beijing Co Ltd
SZSE:300759
Watchlist
Price: 31.41 CNY -0.44% Market Closed
Market Cap: 46.7B CNY
Have any thoughts about
Pharmaron Beijing Co Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

31.4
Current
30.4
Median
19.9
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
31.4
=
Enterprise Value
49.3B CNY
/
EBITDA
1.6B CNY
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
17.2
2-Years Forward
EV/EBITDA
15
3-Years Forward
EV/EBITDA
13.2

See Also

Discover More